Review: could Copaxone cause Arf?


Summary

Arf is found among people who take Copaxone, especially for people who are female, 60+ old , have been taking the drug for 1 - 6 months, also take medication Betaseron, and have Multiple sclerosis . We study 24,950 people who have side effects while taking Copaxone from FDA and social media. Among them, 74 have Arf. Find out below who they are, when they have Arf and more.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Copaxone

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. (latest outcomes from Copaxone 25,477 users)

Arf

Arf (acute renal failure (arf), is a rapid loss of kidney) has been reported by people with breathing difficulty, acute kidney failure, weakness, diarrhea, pneumonia (latest reports from 80,375 Arf patients).

On Sep, 21, 2016

24,950 people reported to have side effects when taking Copaxone.
Among them, 74 people (0.3%) have Arf


Number of reports submitted per year:

Could Copaxone cause Arf?

Time on Copaxone when people have Arf *:

  • < 1 month: 30 %
  • 1 - 6 months: 50 %
  • 6 - 12 months: 20 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Arf when taking Copaxone *:

  • female: 75.34 %
  • male: 24.66 %

Age of people who have Arf when taking Copaxone *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 8.51 %
  • 40-49: 29.79 %
  • 50-59: 29.79 %
  • 60+: 31.91 %

Top conditions involved for these people *:

  • Multiple Sclerosis (68 people, 91.89%)
  • Pain (6 people, 8.11%)
  • Diabetes Mellitus (4 people, 5.41%)
  • Depression (4 people, 5.41%)
  • Urinary Incontinence (3 people, 4.05%)

Top co-used drugs for these people *:

  • Betaseron (8 people, 10.81%)
  • Tysabri (7 people, 9.46%)
  • Lisinopril. (6 people, 8.11%)
  • Avonex (6 people, 8.11%)
  • Ampyra (6 people, 8.11%)

Top other side effects for these people *:

  • Loss Of Consciousness (9 people, 12.16%)
  • Urinary Tract Infection (8 people, 10.81%)
  • Multiple Sclerosis (8 people, 10.81%)
  • Dehydration (8 people, 10.81%)
  • Accidental Overdose (8 people, 10.81%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Arf when taking Copaxone?

Browse all side effects of Copaxone

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Arf

Arf

Could your condition cause Arf

Arf

Related studies

Can you answer these questions?

More questions for: Copaxone, Arf

You may be interested in these reviews

More reviews for: Copaxone, Arf


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.